|
Market Commentary |
|
FIIs propel markets to new highs this week |
The Indian markets outperform its global counterparts and log second straight weekly gains on robust buying by FIIs |
 Major news for the week:- Food inflation softens to 9.5% versus 10.05%
- February exports rise 49.7%
- FDI down by 30% in February to $1.2 billion
- Maruti Suzuki March sales up 28% yoy
- SBI extends teaser home loan scheme by a month
Indian indices
The Indian markets maintained its uptrend for the second week in a row. Strong buying by foreign institutional investors (FIIs) played a major role in boosting the markets. Positive global cues and a decline in food inflation provided further support. The markets witnessed good rollovers on March F&O expiry day. The key indices attained new highs this week on the back of robust FIIs, with the Sensex crossing 19400 levels and the Nifty above the 5800 mark.
The Sensex fluctuated around 775 points between a high of 19575 and a low of 18800 and closed the week at 19420, higher by 605 points or 3.21%. The Nifty swung about 229 points and ended the week at 5826, up 172 points or 3.04%.
 Global indices
The global sentiments remained upbeat. All the world markets closed the week higher. However, Shanghai Composite was the only loser, down by 0.36% on renewed concern about further monetary-policy tightening by the country's central bank. The Sensex outperformed its global peers this week, rising by 3.21%. Following that Hang Seng rose by 2.78% and Nikkei gained by 1.81%. Other global indices gained in the range of 0.14 - 1.39%.
 Sectoral and stock screening
All the sectoral indices closed the week on a strong note. BSE Realty stood the top gainer for the second consecutive week, surging by 7.15%, following that BSE Consumer Durables (CD) rose by 5.97% and BSE Auto advanced by 5.74%. Rest of the indices ended the week higher in the range of 1.58-3.18%.
|
On 'A' group stocks' front, top three gainers of the week ? D B Realty shot up by 20.1%, IL&FS Transportation Networks gained by 16.56% and LIC Housing Finance surged by 13.40%. Top three losers of the week - Piramal Healthcare dropped by 12.98%, Tech Mahindra fell by 6.19% and National Aluminium Co slipped by 4.90%. FII/MF activity
The FIIs were heavy buyers this week and purchased Indian equities worth a net of Rs4,543.4 crore as against net buy of Rs529.4 crore seen in the previous week. The domestic institutional investors (DIIs) sold Indian equities worth a net of Rs364.7 crore as compared to net buy of Rs209.5 crore seen in the previous week. |
| TOP MOVERS (GROUP A) |  | |
|
|
|
|
|
|
|
| Piramal Healthcare | 418.50 | 12.98 |
|
| Tech Mahindra | 690.75 | 6.19 |
|
|
|
|
|
|
| FII/MF ACTIVITIES | | |
|
|
| Gross purchase | 13063 | 1660 |
|
|
|
|
|
|
|
|
|
*As on March 31, 2011
**As on March 30, 2011 |
|
|
Outlook
Major trigger for the markets in the near term is Q4 March 2011 results, which may keep investor participation high. Crude oil prices will remain a major cause of concern. The FIIs' activity and changes across the globe will provide further course of direction to the Indian markets. |
|
|
To know more about our products and services, click here. |
 | Sharekhan Ltd., Regd Add: 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai ? 400 042, Maharashtra. Tel: 022 - 61150000. BSE Cash-INB011073351; F&O-INF011073351; NSE ? INB/INF231073330; CD - INE231073330; MCX Stock Exchange : CD - INE261073330 DP: NSDL-IN-DP-NSDL-233-2003; CDSL-IN-DP-CDSL-271-2004; PMS INP000000662; Mutual Fund: ARN 20669. |
|
|
?This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (?SHAREKHAN and affiliates?) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.? |
|
|
No comments:
Post a Comment